Blog
May 15, 2023
Poster sessions at AACR: a recap
We were grateful for the opportunity to attend and present at the AACR Annual Meeting last week, where three of our scientists highlighted some of the exciting work happening in our Vancouver lab.
The holiday season is around the corner, and we would like to inform everyone of our operation schedule over Christmas and New Year.
The Imagia Canexia Health Laboratory will be closed from Monday, December 26th 2022 to Monday, January 2nd, 2023, inclusive. We will be back to regular operations, Tuesday, January 3rd, 2023.
Deadline for samples
If you ship samples to us as part of your regular operation, please ensure that your patients and oncologists arrange for sample collection well in advance of our closure dates to allow sufficient time to ship specimens to our testing facility. We must receive tissue or blood specimens before the morning of Thursday, December 22nd. Samples received right before or on the morning of December 22nd will be held and tested within our regular turnaround time after the laboratory opens on Jan 3rd 2023.
Contact
Please do not hesitate to reach out to us if you have any questions or concerns regarding sample testing at our facility by sending queries to info@canexiahealth.com.
Our general support line at support@canexiahealth.com will remain operational over the holidays with urgent requests addressed appropriately, however, the response times may be more than our usual 24 hours. We apologize for any inconvenience.
Recent Resources
Press
March 28, 2023
Imagia Canexia Health Announces Three Abstracts to be Presented at AACR Annual Meeting 2023 Highlighting the Company’s Latest Research Findings
Imagia Canexia Health announced that three abstracts highlighting the company’s new learnings and tools will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19, 2023, at the Orange County Convention Center in Orlando, Florida.
Webinar
March 27, 2023
Project ACTT Webinar
Project ACTT (Access to Cancer Testing and Treatment) in Response to COVID-19 was a joint effort led by Imagia Canexia Health and supported by Digital Supercluster and partner institutions.